| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/12/2013 | CA2448022C Compositions for protein delivery via the pulmonary route |
| 11/08/2013 | CA2793894A1 Cylodextrin complexation methods for formulating peptide proteasome inhibitors |
| 11/08/2013 | CA2783146A1 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
| 11/07/2013 | WO2013166436A1 Pharmaceutical nanoparticles showing improved mucosal transport |
| 11/07/2013 | WO2013166408A1 Pharmaceutical nanoparticles showing improved mucosal transport |
| 11/07/2013 | WO2013166399A1 Ophthalmic compositions with improved dessication protection and retention |
| 11/07/2013 | WO2013166385A1 Pharmaceutical nanoparticles showing improved mucosal transport |
| 11/07/2013 | WO2013165940A1 Anti-pmel17 antibodies and immunoconjugates |
| 11/07/2013 | WO2013165264A1 Anthelmintic compositions |
| 11/07/2013 | WO2013165262A1 Peptides, constructs and uses therefor |
| 11/07/2013 | WO2013164684A1 Veterinary kit and method for compounding medicated treats |
| 11/07/2013 | WO2013164636A1 Avermectin pour-on formulation with reduced withdrawal time |
| 11/07/2013 | WO2013164473A1 Pharmaceutical composition comprising abiraterone acetate |
| 11/07/2013 | WO2013164380A1 Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections |
| 11/07/2013 | WO2013164316A1 A delayed release drug formulation |
| 11/07/2013 | WO2013164315A1 A delayed release drug formulation |
| 11/07/2013 | WO2013164122A1 Aqueous dispersions of controlled release polymers and shells and capsules thereof |
| 11/07/2013 | WO2013164121A1 Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
| 11/07/2013 | WO2013163738A1 Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients |
| 11/07/2013 | WO2013163734A1 Topical non-aqueous pharmaceutical formulations |
| 11/07/2013 | WO2013125730A3 Cationic graft-copolymer for drug delivery system |
| 11/07/2013 | WO2013084208A3 Liposomes and corresponding production method |
| 11/07/2013 | WO2013028904A3 Dermal filler compositions including antioxidants |
| 11/07/2013 | WO2013009701A9 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| 11/07/2013 | WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 11/07/2013 | US20130296531 Block copolymers for stable micelles |
| 11/07/2013 | US20130296460 In situ bonds |
| 11/07/2013 | US20130296446 Aqueous ophthalmic composition |
| 11/07/2013 | US20130296444 Copolymer, composition and method for modifying rheology |
| 11/07/2013 | US20130296442 Lutein/zeaxanthin for glare protection |
| 11/07/2013 | US20130296423 Pharmaceutical compositions comprising fesoterodine |
| 11/07/2013 | US20130296419 Products containing polyphenol(s) and l-arginine |
| 11/07/2013 | US20130296365 Quinoline derivative-containing pharmaceutical composition |
| 11/07/2013 | US20130296337 Flashmelt oral dosage formulation |
| 11/07/2013 | US20130296285 Design of Hydrolytically Releasable Prodrugs for Sustained Release Nanoparticle Formulations |
| 11/07/2013 | US20130296280 Eutectic mixture comprising celecoxib and poloxamer |
| 11/07/2013 | US20130296268 Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process |
| 11/07/2013 | US20130296266 Pharmaceutical Composition of Complex Carbohydrates and Essential Oils and Methods of Using the Same |
| 11/07/2013 | US20130296263 Hyaluronic acid stabilizer |
| 11/07/2013 | US20130296262 Hyaluronic acid stabilizer |
| 11/07/2013 | US20130296259 Pharmaceutical compositions containing botulinum neurotoxin |
| 11/07/2013 | US20130296235 Container and method for storing a pharmaceutical agent |
| 11/07/2013 | US20130296227 Antimicrobial cationic peptides and formulations thereof |
| 11/07/2013 | US20130296165 Stabilizing Composition for Biological Materials |
| 11/07/2013 | US20130295639 Branched Polymers |
| 11/07/2013 | US20130295191 Stable Formulations for Lyophilizing Therapeutic Particles |
| 11/07/2013 | US20130295187 NOVEL FORMULATIONS OF FACTOR VIIa INHIBITORS AND UTILITY |
| 11/07/2013 | US20130295186 Method for coating particles with calcium phosphate and particles, microparticles and nanoparticles formed thereof |
| 11/07/2013 | US20130295180 Salt product |
| 11/07/2013 | US20130295165 Compositions and methods for treating viral infections |
| 11/07/2013 | US20130295158 Composition for the transdermal delivery of fentanyl |
| 11/07/2013 | US20130295132 Conjugation of Streptococcal Capsular Saccharides |
| 11/07/2013 | US20130295128 Chimeric vaccines |
| 11/07/2013 | US20130295119 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof |
| 11/07/2013 | US20130295118 Antibodies specific for cll-1 |
| 11/07/2013 | US20130295094 Use of a vegf antagonist to treat angiogenic eye disorders |
| 11/07/2013 | US20130295073 Use of pegylated recombinant human arginase for treatment of leukemia |
| 11/07/2013 | US20130295052 Novel conjugates for targeted drug delivery |
| 11/07/2013 | US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs |
| 11/07/2013 | US20130295040 Polymer |
| 11/07/2013 | US20130295039 Polymer conjugates with a linker |
| 11/07/2013 | US20130295037 In situ bonds |
| 11/07/2013 | US20130295026 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin |
| 11/06/2013 | EP2660327A1 Method for utilizing monoterpene glycosyltransferase |
| 11/06/2013 | EP2660255A1 Block copolymers for stable micelles |
| 11/06/2013 | EP2660247A2 High penetration prodrug compositions of peptides and peptide-related compounds |
| 11/06/2013 | EP2659912A2 Conjugate purification |
| 11/06/2013 | EP2659911A1 Aqueous ophthalmic composition |
| 11/06/2013 | EP2659903A2 Nanoemulsion-type ophthalmic composition |
| 11/06/2013 | EP2659902A1 Leuprolide injection |
| 11/06/2013 | EP2659895A1 Pharmaceutical composition including hyaluronic acid and a zinc compound and corresponding bar on a stick and preparation method |
| 11/06/2013 | EP2659894A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 11/06/2013 | EP2659889A1 Antipyretic/analgesic composition |
| 11/06/2013 | EP2659886A1 Patch |
| 11/06/2013 | EP2659882A1 Decay-type nuclear particle for pharmaceutical formulation |
| 11/06/2013 | EP2659881A1 A delayed release drug formulation |
| 11/06/2013 | EP2658982A1 Small molecule conjugates for intracellular delivery of biologically active compounds |
| 11/06/2013 | EP2658981A1 Small molecule conjugates for intracellular delivery of nucleic acids |
| 11/06/2013 | EP2658979A1 Compositions comprising natriuretic peptides and methods of use thereof |
| 11/06/2013 | EP2658578A1 Cellular hydration compositions containing cyclodextrins |
| 11/06/2013 | EP2658577A2 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
| 11/06/2013 | EP2658576A1 Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
| 11/06/2013 | EP2658575A1 Pharmaceutical formulation comprising a biopharmaceutical drug |
| 11/06/2013 | EP2658574A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer |
| 11/06/2013 | EP2658542A2 Topical localized isoxazoline formulation |
| 11/06/2013 | EP2658541A1 Topical localized isoxazoline formulation comprising glycofurol |
| 11/06/2013 | EP2658539A2 Composition for prevention of nausea or vomiting |
| 11/06/2013 | EP2658529A2 Ocular drug delivery system |
| 11/06/2013 | EP2658526A1 Foamable compositions of stabilized chlorite |
| 11/06/2013 | EP2658525A2 Biodegradable drug delivery compositions |
| 11/06/2013 | EP2658517A1 Improved powderous vitamin e formulations |
| 11/06/2013 | EP1854454B1 Method for the preparation of amorphous telmisartan |
| 11/06/2013 | CN103384534A Branched linker for protein drug conjugates |
| 11/06/2013 | CN103384533A Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
| 11/06/2013 | CN103384518A Novel antifungal composition |
| 11/06/2013 | CN103384513A Nasal compositions of vitamin B12 |
| 11/06/2013 | CN103382218A Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof |
| 11/06/2013 | CN103382217A Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof |
| 11/06/2013 | CN103381273A Doxorubicin prodrug, its preparation method and injectable composition |
| 11/06/2013 | CN103381272A Method for improving levodropropizine taste by cyclodextrin clathration |